Erlend B. Smeland

Oslo, Norway

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 47 publications

Multi-omics profiling of longitudinal samples reveals early genomic changes in follicular lymphoma.

Multi-omics profiling of longitudinal samples reveals early genomic changes in follicular lymphoma.

Journal: Blood cancer journal
Published: January 19, 2024

Diversity of intratumoral regulatory T cells in B-cell non-Hodgkin lymphoma.

Diversity of intratumoral regulatory T cells in B-cell non-Hodgkin lymphoma.

Journal: Blood advances
Published: March 08, 2023

The Geriatric Prognostic Index: a clinical prediction model for survival of older diffuse large B-cell lymphoma patients treated with standard immunochemotherapy.

The Geriatric Prognostic Index: a clinical prediction model for survival of older diffuse large B-cell lymphoma patients treated with standard immunochemotherapy.

Journal: Haematologica
Published: December 13, 2022

Efficient chimeric antigen receptor targeting of a central epitope of CD22.

Efficient chimeric antigen receptor targeting of a central epitope of CD22.

Journal: The Journal of biological chemistry
Published: November 17, 2022

Mechanism of CD79A and CD79B Support for IgM+ B Cell Fitness through B Cell Receptor Surface Expression.

Mechanism of CD79A and CD79B Support for IgM+ B Cell Fitness through B Cell Receptor Surface Expression.

Journal: Journal of immunology (Baltimore, Md. : 1950)
Published: February 18, 2022

A simplified frailty score predicts survival and can aid treatment-intensity decisions in older patients with DLBCL.

A simplified frailty score predicts survival and can aid treatment-intensity decisions in older patients with DLBCL.

Journal: Blood advances
Published: March 18, 2021

Combinatorial CAR design improves target restriction.

Combinatorial CAR design improves target restriction.

Journal: The Journal of biological chemistry
Published: October 09, 2020

MAPK and JAK-STAT pathways dysregulation in plasmablastic lymphoma.

MAPK and JAK-STAT pathways dysregulation in plasmablastic lymphoma.

Journal: Haematologica
Published: September 24, 2020

Karonudib has potent anti-tumor effects in preclinical models of B-cell lymphoma.

Karonudib has potent anti-tumor effects in preclinical models of B-cell lymphoma.

Journal: Scientific reports
Published: September 22, 2020

The DLBCL90 gene-expression assay identifies double-hit lymphomas with high sensitivity in patients from two phase II clinical trials with high-risk diffuse large B-cell lymphoma.

The DLBCL90 gene-expression assay identifies double-hit lymphomas with high sensitivity in patients from two phase II clinical trials with high-risk diffuse large B-cell lymphoma.

Journal: EJHaem
Published: September 04, 2020

Mutational dynamics and immune evasion in diffuse large B-cell lymphoma explored in a relapse-enriched patient series.

Mutational dynamics and immune evasion in diffuse large B-cell lymphoma explored in a relapse-enriched patient series.

Journal: Blood advances
Published: December 09, 2019

A clinico-molecular predictor identifies follicular lymphoma patients at risk of early transformation after first-line immunotherapy.

A clinico-molecular predictor identifies follicular lymphoma patients at risk of early transformation after first-line immunotherapy.

Journal: Haematologica
Published: March 09, 2019
Showing 1-12 of 47

Last Updated: 09/26/2026